Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial. (Q52650640)

5 May 2018

title

Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial. (English)

1 reference

5 May 2018

0 references

1

Firdausi Qadri

1 reference

5 May 2018

Arifuzzaman Khan

18

0 references

Jean-Louis Excler

7

Jean-Louis Excler

1 reference

5 May 2018

John Clemens

25

John D Clemens

1 reference

5 May 2018

Fahima Chowdhury

4

Fahima Chowdhury

1 reference

5 May 2018

Taufiqur Rahman Bhuiyan

11

Taufiqur R Bhuiyan

1 reference

5 May 2018

Farhana Khanam

12

Farhana Khanam

1 reference

5 May 2018

Ashraful Islam Khan

5

Ashraful Islam Khan

1 reference

5 May 2018

Muhammad Asaduzzaman

19

Muhammad Asaduzzaman

1 reference

5 May 2018

Iqbal Ansary Khan

14

Iqbal Ansary Khan

1 reference

5 May 2018

Afroza Akter

17

Afroza Akter

1 reference

5 May 2018

Md Taufiqul Islam

9

Md Taufiqul Islam

1 reference

5 May 2018

Baizid Khoorshid Riaz

16

Baizid Khoorshid Riaz

1 reference

5 May 2018

Thomas F Wierzba

6

Thomas F Wierzba

1 reference

5 May 2018

Mohiul Islam Chowdhury

13

Mohiul I Chowdhury

1 reference

5 May 2018

Ashraf U Siddik

21

Ashraf U Siddik

1 reference

5 May 2018

Nirod Chandra Saha

22

Nirod C Saha

1 reference

5 May 2018

Deok Ryun Kim

20

Deok Ryun Kim

1 reference

5 May 2018

author name string

Mohammad Ali

2

1 reference

5 May 2018

Julia Lynch

3

1 reference

5 May 2018

Amit Saha

8

1 reference

5 May 2018

Yasmin A Begum

10

1 reference

5 May 2018

Alamgir Kabir

15

1 reference

5 May 2018

Alejandro Cravioto

23

1 reference

5 May 2018

Ajit P Singh

24

1 reference

5 May 2018

publication date

14 March 2018

1 reference

5 May 2018

Lancet Infectious Diseases

published in

1 reference

5 May 2018

New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Updated global burden of cholera in endemic countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

A second affordable oral cholera vaccine: implications for the global vaccine stockpile

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

A highly selective gelatin-taurocholate-tellurite medium for the isolation of Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

A simulation study of the number of events per variable in logistic regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Use of Vibrio cholerae vaccine in an outbreak in Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930108-7

7 January 2021

10.1016/S1473-3099(18)30108-7

Identifiers

DOI

1 reference

5 May 2018

PubMed ID

29550406

1 reference

5 May 2018